Abstract:Fibrous technologies (such as membranes, films, patches and filters) and their enabling engineering platforms have gained considerable interest over the last decade. In this study, novel fibrous constructs from a unique engineering platform were developed based on hybrid electrohydrodynamic (EHD) technology; incorporating functional and bioactive materials within random and aligned fibrous formulation geometries. Complex constructs were engineered using 3D printing (polycaprolactone, PCL, for sustained delivery) and electrospinning (polyvinylpyrrolidone, PVP, for rapid release) in an intercalating material layer-by-layer format using a side-by-side technological approach. Here, structure generation proceeded with deposition of ordered PCL fibers enabling well-defined void size and overall dimension, after which randomly spun PVP fibers formed a construct overcoat (as a membrane). Differences between polymer dissolution rate, hydrophilicity, mechanical properties and functional material hosting (and linked external auxiliary magnetic field trigger) provided opportunities to modulate antibiotic drug (tetracycline hydrochloride, TE-HCl) release. In vitro cell studies using human umbilical vein blood vessel cell line demonstrated device biocompatibility and Escherichia Coli (E. coli) was selected to demonstrate anti-bacterial function. Overall, a new hybrid engineering platform to prepare customizable and exciting multi-faceted drug release constructs is elucidated.

A facile technique to prepare biodegradable coaxial electrospun nanofibers for controlled release of bioactive agents.

Modulation of Protein Release from Biodegradable Core-Shell Structured Fibers Prepared by Coaxial Electrospinning.

Development of Random and Ordered Composite Fiber Hybrid Technologies for Controlled Release Functions

Coaxial Electrospinning for Encapsulation and Controlled Release of Fragile Water-Soluble Bioactive Agents.

Aqueous-Based Coaxial Electrospinning of Genetically Engineered Silk Elastin Core-Shell Nanofibers

Biodegradable Fibrous Scaffolds Composed Of Gelatin Coated Poly(Epsilon-Caprolactone) Prepared By Coaxial Electrospinning

Designer Fibers from 2D to 3D – Simultaneous and Controlled Engineering of Morphology, Shape and Size

Encapsulation and controlled release of lysozyme from electrospun poly(epsilon-caprolactone)/poly(ethylene glycol) non-woven membranes by formation of lysozyme-oleate complexes.

Core-Shell Nanoparticles Fabricated By Tri-Capillary Coaxial Electrospray And Template Removal Method For Protein Delivery

Encapsulation and controlled release of lysozyme from electrospun poly(ε-caprolactone)/poly(ethylene glycol) non-woven membranes by formation of lysozyme–oleate complexes

Emulsion Electrospinning of Nanofibrous Delivery Vehicles for the Controlled Release of Biomolecules and the in Vitro Release Behaviour of Biomolecules

Electrospinning of Biomacromolecules for Controlled Drug Release

Fabrication and characterization of zein-based nanofibrous scaffolds by an electrospinning method.

Nanofibrous Mats of Rigid Polysaccharides Prepared by Coaxial Electrospinning

Preparation of Coaxial-Electrospun Poly[bis(p-methylphenoxy)]phosphazene Nanofiber Membrane for Enzyme Immobilization

Biodegradable Hyaluronic Acid/n-Carboxyethyl Chitosan/protein Ternary Complexes As Implantable Carriers for Controlled Protein Release.

The release kinetic of drug encapsulated poly(L-lactide-co-ɛ-caprolactone) core-shell nanofibers fabricated by emulsion electrospinning

Electrospun quad-axial nanofibers for controlled and sustained drug delivery

Encapsulation of Drug Reservoirs in Fibers by Emulsion Electrospinning: Morphology Characterization and Preliminary Release Assessment

Electrospun Janus zein–PVP nanofibers provide a two-stage controlled release of poorly water-soluble drugs

Encapsulation of lycopene into electrospun nanofibers from whey protein isolate- Tricholoma lobayense polysaccharide complex stabilized emulsions: Structural characterization, storage stability, in vitro release, and cellular evaluation